|Downtime form:||A-1a Doctor/Provider Orders - Pathology Core and Specialty Care Nursery|
|Red top tube 5 mL (Clot Activator)|
Antibodies to infliximab (ATI) concentration: <3.1 U/mL
A lower cost option for testing is Adalimumab Activity and Neutralizing Antibody, LAB8152. Obtaining pre-authorization to estimate patient out-of-pocket liability is strongly recommended. Once obtained draw sample at patient's next available visit. Please use the reference link below for authorization. Patient's insurance information must be submitted with the sample. Advantages •Anser™ IFX can detect low levels of ATI even in the presence of high levels of circulating drug (60μg/mL of IFX in serum) •Anser™ IFX can be performed at any time during therapy with IFX, with no trough level sampling limitation •High assay sensitivity, specificity, and accuracy •Use Anser™ IFX to help determine personalized solutions for managing loss of response to IFX
Please print, complete, and submit the Pre-Authorization Form and the Prometheus Test Requisition from Prometheus Lab.
Adalimumab Activity and Neutralizing Antibody, Serum
Specimens Requiring Immediate Delivery